- Home
- APVO vs RSLS Comparison
APVO vs RSLS Comparison
Compare APVO & RSLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- RSLS
- Stock Information
- Founded
- APVO 2016
- RSLS 2002
- Country
- APVO United States
- RSLS United States
- Employees
- APVO N/A
- RSLS N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- RSLS Medical/Dental Instruments
- Sector
- APVO Health Care
- RSLS Health Care
- Exchange
- APVO Nasdaq
- RSLS Nasdaq
- Market Cap
- APVO 3.7M
- RSLS 3.0M
- IPO Year
- APVO N/A
- RSLS 2007
- Fundamental
- Price
- APVO $0.21
- RSLS $5.24
- Analyst Decision
- APVO Strong Buy
- RSLS Hold
- Analyst Count
- APVO 1
- RSLS 1
- Target Price
- APVO $8.00
- RSLS N/A
- AVG Volume (30 Days)
- APVO 17.5M
- RSLS 180.6K
- Earning Date
- APVO 11-07-2024
- RSLS 11-14-2024
- Dividend Yield
- APVO N/A
- RSLS N/A
- EPS Growth
- APVO N/A
- RSLS N/A
- EPS
- APVO N/A
- RSLS N/A
- Revenue
- APVO N/A
- RSLS $8,183,000.00
- Revenue This Year
- APVO N/A
- RSLS $17.47
- Revenue Next Year
- APVO N/A
- RSLS $20.00
- P/E Ratio
- APVO N/A
- RSLS N/A
- Revenue Growth
- APVO N/A
- RSLS N/A
- 52 Week Low
- APVO $0.14
- RSLS $4.60
- 52 Week High
- APVO $10.80
- RSLS $34.22
- Technical
- Relative Strength Index (RSI)
- APVO 43.68
- RSLS 42.38
- Support Level
- APVO $0.24
- RSLS $4.88
- Resistance Level
- APVO $0.33
- RSLS $5.89
- Average True Range (ATR)
- APVO 0.04
- RSLS 0.68
- MACD
- APVO -0.01
- RSLS 0.00
- Stochastic Oscillator
- APVO 0.70
- RSLS 17.80
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage, research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidate, APVO436, and preclinical candidates, ALG.APV-527 and APVO603, were developed using ADAPTIR modular protein technology platform. The versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About RSLS ReShape Lifesciences Inc.
Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus.